E Fund Management Co. Ltd. Sells 2,327 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

E Fund Management Co. Ltd. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 26.7% during the second quarter, HoldingsChannel reports. The firm owned 6,381 shares of the healthcare conglomerate’s stock after selling 2,327 shares during the period. E Fund Management Co. Ltd.’s holdings in UnitedHealth Group were worth $3,250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Macroview Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. True Wealth Design LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $31,000. Delos Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new position in UnitedHealth Group in the second quarter valued at about $31,000. Finally, Signature Resources Capital Management LLC lifted its holdings in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on UNH. Truist Financial increased their target price on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Argus upped their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, HSBC raised their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $614.17.

Get Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Trading Down 1.9 %

UNH opened at $577.89 on Wednesday. The stock’s fifty day moving average is $572.79 and its two-hundred day moving average is $519.00. The company has a market capitalization of $531.88 billion, a P/E ratio of 35.32, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the business posted $6.14 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).